Live market news
Stocks
CLDI

Calidi Biotherapeutics, Inc.

CLDIStockUnited States

See in Charts

Latest news on CLDIranked by Oyticker for market impact

78Impact
NegativeMajor information25 Sept 2026 · 21:00 UTC · Global · Short term
CLDI Receives NYSE American Delisting Notice for Stockholders' Equity Deficiency
Calidi Biotherapeutics received a non-compliance notice from NYSE American on September 21, 2026, for failing to maintain the required $4.0 million minimum stockholders' equity while reporting losses in three of four recent fiscal years and not qualifying for available exemptions.
CLDIBiotechnologyCapital Markets

SEC filings

What CLDI filed

All its filings

25 Sept 2026
Listing notice (opens the document on sec.gov)8-K
Other event
22 Sept 2026
Material agreement (opens the document on sec.gov)8-K
Other event
13 Aug 2026
Quarterly report (opens the document on sec.gov)10-Q
13 Aug 2026
Results announced (opens the document on sec.gov)8-K
Investor communication
31 Jul 2026
Change to shareholders' rights (opens the document on sec.gov)8-K
Bylaws or fiscal year changed
16 Jul 2026
Material agreement (opens the document on sec.gov)8-K
Agreement ended · New debt or obligation
23 Jun 2026
Executive or director change (opens the document on sec.gov)8-K
Investor communication · Other event
18 Jun 2026
Shareholder vote results (opens the document on sec.gov)8-K
29 May 2026
Material agreement (opens the document on sec.gov)8-K
Unregistered share sale
14 May 2026
Quarterly report (opens the document on sec.gov)10-Q
14 May 2026
Results announced (opens the document on sec.gov)8-K
Investor communication

From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.

Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.

Latest news on CLDIranked by Oyticker for market impact

CLDI Receives NYSE American Delisting Notice for Stockholders' Equity Deficiency

What CLDI filed